Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/THEMISMED stock hub

NSE/THEMISMED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/THEMISMEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/THEMISMED

In the news

Latest news · NSE/THEMISMED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/En/a

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC-4.2

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/THEMISMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

INR

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,702
Employees Change	193%
Employees Change Percent	12.79
Enterprise value	INR 9.9B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE083B01024
Last refreshed	2026-05-10
Market cap	INR 9B
Price	INR 97.1
Price currency	INR
Rev Per Employee	1,982,412.46x
Sector	Healthcare
Sic	5912
Symbol	nse/THEMISMED
Website	https://www.themismedicare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.93%
EV Earnings	-56.59x
EV/Sales	2.92x
P/B ratio	2.37x
P/S ratio	2.67x
PE Ratio10 Y	27.9x
PE Ratio3 Y	38.49x
PE Ratio5 Y	26.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.75%
EBITDA Margin	-3.32%
Gross margin	61.88%
Gross Profit	INR 2.1B
Gross Profit Growth	-25.12%
Gross Profit Growth Q	-6.66%
Gross Profit Growth3 Y	-3.72%
Gross Profit Growth5 Y	7.16%
Net Income	INR -174.1M
Net Income Growth Q	1,843.69%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-5.41%
Profit Margin	-5.16%
Profit Per Employee	INR -102,268
Profitable Years	6
Roa5y	7.38
Roe5y	16.91
ROIC	-4.19
Roic5y	11.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.26%
Cagr15y	12.56%
Cagr1y	-22.18%
Cagr3y	-13.25%
Cagr5y	17.09%
Div CAGR10	11.07%
Div CAGR3	0%
Div CAGR5	3.06%
EPS Growth Q	1,716.7
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-21.83x
Revenue Growth Q	-3.92x
Revenue Growth Years	2x
Revenue Growth3 Y	-1.59x
Revenue Growth5 Y	9.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 127.5M
Debt	INR 955.6M
Debt Equity	INR 0.25
Equity	INR 3.8B
Interest Coverage	-2.18
Net Cash	INR -828.2M
Net Cash By Market Cap	INR -9.18
Net Debt Equity	INR 0.22
Tangible Book Value	INR 3.8B
Tangible Book Value Per Share	INR 40.97
WACC	6.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.17%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 0.5
Dividend Years	6
Dividend Yield	0.5%
Ex Div Date	2025-09-04
Last Dividend	INR 0.5
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	142.32%
1Y total return	-22.17%
200-day SMA	102.5
3Y total return	-34.72%
50-day SMA	84.43
50-day SMA vs 200-day SMA	50under200
5Y total return	120.02%
All Time High	317
All Time High Change	-69.37%
All Time High Date	2024-11-18
All Time Low	4
All Time Low Change	2,327.5%
All Time Low Date	2013-09-04
ATR	4.49
Beta	0.42
Ch YTD	-3.48
High	100
High52	176
High52 Date	2025-05-19
High52ch	-44.83%
Low	97.1
Low52	64.95
Low52 Date	2026-03-30
Low52ch	49.5%
Ma50ch	15.01%
Price vs 200-day SMA	-5.3%
RSI	63.66
RSI Monthly	41.71
RSI Weekly	50.64
Sharpe ratio	-0.28x
Sortino ratio	-0.36
Total Return	0.68%
Tr YTD	-3.48
Tr15y	489.76%
Tr1m	23.69%
Tr1w	-2.2%
Tr3m	16.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -194.1M
Operating Income Growth Q	20.31
Operating margin	-5.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23,565,476%
Shares Insiders	63.87%
Shares Institutions	1.59%
Shares Qo Q	-0.11%
Shares Yo Y	-0.17%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	70,455.45x
Bv Per Share	40.99
Ch10y	136.1
Ch15y	463.4
Ch1m	23.69
Ch1w	-2.2
Ch1y	-22.54
Ch3m	16.04
Ch3y	-35.38
Ch5y	115.5
Ch6m	-16.4
Change	-1.86%
Change From Open	-1.92
Close	98.94
Days Gap	0.06
Depreciation Amortization	81,905,000
Dollar Volume	2,847,069.1
Earnings Date	2026-05-30
EBIT	INR -194.1M
EBITDA	INR -112.2M
EPS	INR -1.89
F Score	0
Fiscal Year End	March
Founded	1,952
Income Tax	INR -8.5M
Is Primary Listing	0
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Last Split Date	2023-10-10
Last Split Type	Forward
Ma150	99.1
Ma150ch	-2.02%
Ma20	92.59
Ma20ch	4.87%
Next Earnings Date	2026-05-30
Open	99
Payment Date	2025-10-12
Position In Range	0
Price Date	2026-05-08
Ptbv Ratio	2.38
Relative Volume	0.42x
Revenue	3,374,066,000x
Tax By Revenue	-0.25x
Tr6m	-16.4%
Volume	29,321

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/THEMISMED dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.50 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.1%

0 consecutive years of growth

Total shareholder yield

+0.7%

Next ex-dividend date: 2025-09-04

Performance

NSE/THEMISMED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/THEMISMED?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.6%

Share of float held by funds and institutions

Insider ownership

+63.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

NSE/THEMISMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.7

Neutral momentum band

Price vs 200-day MA

-5.3%

50/200-day relationship not available

Beta (5Y)

0.42

Less volatile than the market

Sharpe ratio

-0.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/THEMISMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/THEMISMED stock rating?

nse/THEMISMED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/THEMISMED analysis?

The full report lives at /stocks/nse/THEMISMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/THEMISMED?

The latest report frames nse/THEMISMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/THEMISMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.